Detalles de la búsqueda
1.
Efficacy and safety of ritlecitinib in adolescents with alopecia areata: Results from the ALLEGRO phase 2b/3 randomized, double-blind, placebo-controlled trial.
Pediatr Dermatol
; 40(6): 1003-1009, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37455588
2.
Efficacy and safety of crisaborole in patients with mild-to-moderate atopic dermatitis and other atopic comorbidities.
Allergy Asthma Proc
; 42(5): 425-431, 2021 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34474712
3.
Demographics and Baseline Disease Characteristics of Early Responders to Crisaborole for Atopic Dermatitis.
J Drugs Dermatol
; 19(6): 619-624, 2020 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32574023
4.
Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial.
Lancet
; 390(10093): 457-468, 2017 07 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-28629665
5.
Efficacy and safety of tofacitinib in older and younger patients with rheumatoid arthritis.
Clin Exp Rheumatol
; 35(3): 390-400, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28079500
6.
Impact of Crisaborole on Sleep Outcomes in Pediatric Patients with Mild-to-Moderate Atopic Dermatitis.
Dermatol Ther (Heidelb)
; 13(4): 951-960, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36811773
7.
Overview of alopecia areata for managed care and payer stakeholders in the United States.
J Manag Care Spec Pharm
; 29(7): 848-856, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37219075
8.
Efficacy and safety of tofacitinib by background methotrexate dose in psoriatic arthritis: post hoc exploratory analysis from two phase III trials.
Clin Rheumatol
; 41(2): 499-511, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34510295
9.
Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by baseline body mass index: an analysis of pooled data from phase 3 studies.
RMD Open
; 8(1)2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35577477
10.
Patient and caregiver preferences on treatment attributes for atopic dermatitis.
J Dermatolog Treat
; 33(4): 2225-2233, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34264145
11.
Efficacy and Safety Trends with Continuous, Long-Term Crisaborole Use in Patients Aged ≥ 2 Years with Mild-to-Moderate Atopic Dermatitis.
Dermatol Ther (Heidelb)
; 11(5): 1667-1678, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34379285
12.
Re-establishment of efficacy of tofacitinib, an oral JAK inhibitor, after temporary discontinuation in patients with rheumatoid arthritis.
Clin Rheumatol
; 39(7): 2127-2137, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32048083
13.
Safety, Effectiveness, and Pharmacokinetics of Crisaborole in Infants Aged 3 to < 24 Months with Mild-to-Moderate Atopic Dermatitis: A Phase IV Open-Label Study (CrisADe CARE 1).
Am J Clin Dermatol
; 21(2): 275-284, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32212104
14.
Live Zoster Vaccine in Patients With Rheumatoid Arthritis Treated With Tofacitinib With or Without Methotrexate, or Adalimumab With Methotrexate: A Post Hoc Analysis of Data From a Phase IIIb/IV Randomized Study.
Arthritis Care Res (Hoboken)
; 72(3): 353-359, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31207152
15.
Real-World Comparative Effectiveness of Tofacitinib and Tumor Necrosis Factor Inhibitors as Monotherapy and Combination Therapy for Treatment of Rheumatoid Arthritis.
Rheumatol Ther
; 2019 Nov 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31707603
16.
A pooled analysis of the safety of tofacitinib as monotherapy or in combination with background conventional synthetic disease-modifying antirheumatic drugs in a Phase 3 rheumatoid arthritis population.
Semin Arthritis Rheum
; 48(3): 406-415, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30177460
17.
Effect of Discontinuation or Initiation of Methotrexate or Glucocorticoids on Tofacitinib Efficacy in Patients with Rheumatoid Arthritis: A Post Hoc Analysis.
Rheumatol Ther
; 5(1): 203-214, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29417430
18.
Evaluation of disease activity in patients with rheumatoid arthritis treated with tofacitinib by RAPID3: post hoc analyses from two phase 3 trials.
Clin Rheumatol
; 37(8): 2043-2053, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29656373
19.
Safety and maintenance of response for tofacitinib monotherapy and combination therapy in rheumatoid arthritis: an analysis of pooled data from open-label long-term extension studies.
RMD Open
; 3(2): e000491, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29435359
20.
Safety and efficacy of eletriptan in the treatment of acute migraine.
Pharmacotherapy
; 26(1): 115-28, 2006 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-16506353